A High-Throughput Approach to Identify BRCA1-Downregulating Compounds to Enhance PARP Inhibitor Sensitivity
Article in iScience (June 2024)
The most recent citing publications are shown below. View all 66 publications that cite this research output on Dimensions.
KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challenges
Article in Molecular Cancer (May 2024)
Emerging role of Jumonji domain-containing protein D3 (JMJD3) in inflammatory diseases
Article in Journal of Pharmaceutical Analysis (April 2024)